Follow us on Twitter
Log In | Sign Up

ESG Investing

Main Menu

  • Home
  • All News
    • All ESG News
    • Research
    • ESG Reports
  • Training
  • Awards
    • Investing
    • Reporting
  • Advisory
  • Exchange
  • Contact

UBS clients invest $650 million in impact fund

ESG Investing Wednesday 6 October 2021 08:51 GMT

UBS Global Wealth Management clients have invested USD 650 million in a bioimpact fund.

The MPM Capital’s Oncology Impact Fund 2 invests in private and public companies developing innovative treatments for cancer. UBS says the sum raised makes the fund the largest dedicated impact investment fund in biotech history.

The fund will target companies developing breakthroughs, innovative treatments, and therapeutics and will be overseen by MPM Capital’s BioImpact Capital team. It will invest 80% of its capital into private companies with the remaining 20% going towards public companies. The fund comes after the UBS Oncology Impact Fund (OIF 1) which closed in 2016.

Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says: “We are proud to connect our clients with brilliant scientists around the world who are working hard to alleviate the pain and suffering caused by cancer. With more than USD 1 billion raised so far, this is what reimagining the power of investing and connecting people for a better world can look like.”

“OIF 2 will focus on oncology as well as cell, gene, and RNA therapies, building off the strong performance of OIF 1,” said Managing Partner of BioImpact Capital and MPM Managing Director Ansbert Gadicke, M.D. “As always, we are driven to ensure that the companies we invest in are at the vanguard of innovation, developing breakthroughs and innovative therapeutics.”

 

Categories

Climate

Companies

ESG & Sustainability Reports

ESG Research

Funds

Vendors

About ESG Investing

ESG Investing is the leading global media platform publishing news and features on ESG and sustainable investing for fund managers, institutional investors and listed companies. ESG Investing is a division of Global Markets Media Ltd.

Get in Touch

ESG Investing, Global Markets Media T: +44 (0)1483 573150
E:info@esginvesting.co.uk
A:
ESG Investing
Global Markets Media Ltd
96 High Street
Guildford
GU1 3HE, UK
Copyright © 2022 Global Markets Media

Footer Menu

  • Cookies
  • Disclaimer
Design by Web Design London
7ads6x98y
This website uses cookies to store information on your computer. See our cookie policy for details on how to block cookies.
I am happy to proceed